Total Holdings
169
Portfolio diversification across 169 positions

Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
View ticker symbols, company names, asset types, and allocation percentages for each position
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 | ![]() | Moderna, Inc. | Stock | 0.95% |
| 2 | ![]() | Revolution Medicines, Inc | Stock | 0.93% |
| 3 | ![]() | Amicus Therapeutics, Inc | Stock | 0.86% |
| 4 | ![]() | Halozyme Therapeutics, Inc | Stock | 0.85% |
| 5 | ![]() | Mirum Pharmaceuticals, Inc. | Stock | 0.84% |
| 6 | ![]() | Vaxcyte, Inc. | Stock | 0.82% |
| 7 | ![]() | Incyte Corporation | Stock | 0.82% |
| 8 | ![]() | BioMarin Pharmaceutical Inc | Stock | 0.81% |
| 9 | ![]() | Exelixis, Inc | Stock | 0.79% |
| 10 | ![]() | Praxis Precision Medicines, Inc | Stock | 0.79% |
| 11 | ![]() | Regeneron Pharmaceuticals, Inc | Stock | 0.79% |
| 12 | ![]() | Gilead Sciences, Inc. | Stock | 0.78% |
| 13 | ![]() | GRAIL, LLC | Stock | 0.77% |
| 14 | ![]() | Natera, Inc | Stock | 0.77% |
| 15 | ![]() | Alkermes plc | Stock | 0.77% |
| 16 | ![]() | Vertex Pharmaceuticals Incorporated | Stock | 0.77% |
| 17 | ![]() | Roivant Sciences Ltd | Stock | 0.77% |
| 18 | ![]() | Cytokinetics, Incorporated | Stock | 0.77% |
| 19 | ![]() | Amgen Inc | Stock | 0.76% |
| 20 | ![]() | Celcuity LLC | Stock | 0.76% |
| 21 | ![]() | Ionis Pharmaceuticals, Inc | Stock | 0.75% |
| 22 | ![]() | Travere Therapeutics Inc | Stock | 0.74% |
| 23 | ![]() | Biogen Inc | Stock | 0.74% |
| 24 | ![]() | Alnylam Pharmaceuticals, Inc | Stock | 0.74% |
| 25 | ![]() | PTC Therapeutics, Inc | Stock | 0.74% |
| 26 | ![]() | United Therapeutics Corporation | Stock | 0.73% |
| 27 | ![]() | AbbVie Inc | Stock | 0.73% |
| 28 | ![]() | Krystal Biotech, Inc | Stock | 0.73% |
| 29 | ![]() | BridgeBio Pharma, Inc | Stock | 0.72% |
| 30 | ![]() | Madrigal Pharmaceuticals, Inc | Stock | 0.72% |
| 31 | ![]() | Avidity Biosciences Inc | Stock | 0.72% |
| 32 | ![]() | CRISPR Therapeutics AG | Stock | 0.71% |
| 33 | ![]() | Exact Sciences Corporation | Stock | 0.71% |
| 34 | ![]() | TG Therapeutics, Inc | Stock | 0.70% |
| 35 | ![]() | Scholar Rock Holding Corp | Stock | 0.69% |
| 36 | ![]() | Rhythm Pharmaceuticals, Inc | Stock | 0.68% |
| 37 | ![]() | Arrowhead Pharmaceuticals, Inc | Stock | 0.67% |
| 38 | ![]() | ADMA Biologics, Inc | Stock | 0.66% |
| 39 | ![]() | Summit Therapeutics PLC | Stock | 0.66% |
| 40 | ![]() | ACADIA Pharmaceuticals Inc | Stock | 0.66% |
| 41 | ![]() | Insmed Incorporated | Stock | 0.65% |
| 42 | ![]() | Neurocrine Biosciences, Inc | Stock | 0.64% |
| 43 | ![]() | Protagonist Therapeutics Inc | Stock | 0.64% |
| 44 | ![]() | Beam Therapeutics Inc | Stock | 0.62% |
| 45 | ![]() | Arcutis Biotherapeutics, Inc | Stock | 0.62% |
| 46 | ![]() | Viking Therapeutics Inc | Stock | 0.61% |
| 47 | ![]() | Nuvalent Inc | Stock | 0.60% |
| 48 | ![]() | Ideaya Biosciences Inc | Stock | 0.58% |
| 49 | ![]() | Recursion Pharmaceuticals, Inc. Class A Common Stock | Stock | 0.57% |
| 50 | ![]() | Sarepta Therapeutics, Inc | Stock | 0.56% |